The vast Global Digital Trade Expo in Hangzhou stood as a rebuke to U.S. efforts to hem in China’s technology. But the real competition is internal, and profits are hard to find.
China tech cities like Beijing, Shanghai, and Shenzhen are emerging as global innovation hubs in AI and advanced technologies. These cities offer foreign investors targeted opportunities in sectors ...
BEIJING] China kicked off Wednesday (Oct 1) a new visa programme aimed at attracting foreign talent in science and technology, part of ongoing efforts to position itself as a world leader in those ...
Al Jazeera on MSN
How does China’s K visa work and can it compete with the H-1B?
China is rolling out a new visa aimed at foreign talent in STEM just as the US is tightening eligibility for the H-1B.
Trip.com added a piece to strengthen its global corporate travel ambitions by buying UK-based Key Travel’s operations across EMEA.
12hon MSN
Want to work in China? H‑1B rival K visa opens today, here’s what it offers and how to apply
Unlike the U.S. H‑1B, the K visa does not require employer sponsorship—marking a significant shift in China’s strategy to compete in the global talent market.
Investors are keenly awaiting more details about China’s energy-transition plans for the next decade, after President Xi Jinping announced high-level targets last week at a United Nations meeting.
China's new K visa, effective October 1, 2025, targets young global STEM graduates, offering entry and work authorization without prior job offers. Th ...
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. In December 2011, Jensen Huang arrived onstage at a developer’s conference in Beijing armed with an ...
IFA, held annually in Berlin since 1924, is the world’s largest showcase of home and consumer electronics that shape how we live. Each year, it offers a glimpse of what’s next for households around ...
India’s deepening trade dependence on China contrasts with ongoing political tensions, as Chinese imports dominate key sectors. Despite self-reliance efforts, replacing China in India’s supply chains ...
NewCo’ licensing of clinical candidates is allowing Chinese biotechs to offload costs while expanding profits on a global scale.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback